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Helper T Cell Differentiation
Is Controlled by the Cell Cycle
Cytokines play a dominant role in differentiation under
most experimental conditions, with IL-12 and IL-4 direct-
ing Th1 and Th2 development, respectively (reviewed
Jennifer J. Bird,*³ Daniel R. Brown,³
Alan C. Mullen,³ Naomi H. Moskowitz,*³
Michael A. Mahowald,*³ Jenny R. Sider,*³
Thomas F. Gajewski,*² Chyung-Ru Wang,²³ and referenced in Abbas et al., 1996; O'Garra, 1998).
Apart from the potent effect of cytokines, other factorsand Steven L. Reiner*³§‖
*Department of Medicine such as genetic background (GuÈ ler et al., 1996; Guery
et al., 1997; Launois et al., 1997) and, most notably,²Department of Pathology
³Gwen Knapp Center for Lupus antigen dose and costimulation (or ªsignal-strengthº)
can regulate Th1/Th2 balance (Bluestone, 1995; Thomp-and Immunology Research
§Committee on Developmental Biology son, 1995; Abbas et al., 1996; O'Garra, 1998). Current
models suggest that greater antigen dose and costimu-and Committee on Immunology
The University of Chicago lation are needed to achieve Th2 differentiation (Bret-
scher et al., 1992; Corry et al., 1994; Lu et al., 1994;Chicago, IL 60637
Bluestone, 1995; Hosken et al., 1995; Thompson, 1995;
Abbas et al., 1996; Brown et al., 1997a; Fowell et al.,
1997; Keane-Myers et al., 1997).Summary
Over 20 years ago, it was reasoned that the cell cycle
and in particular DNA synthesis would provide a windowHelper T (Th) cell differentiation is highly regulated
of opportunity to remodel genes from an inactive toby cytokines but initiated by mitogens. By examining
active state (Weintraub et al., 1978). Studies of the non-gene expression in discrete generations of dividing
cytokine requirements for selective subset inductioncells, we have delineated the relationship between
and the kinetics of cytokine gene expression suggestproliferation and differentiation. Initial expression of
an important role for the cell cycle in helper T cell differ-IL-2 is cell cycle-independent, whereas effector cyto-
entiation. In particular, IL-2, an autocrine growth factorkine expression is cell cycle-dependent. IFNg expres-
that drives G1 to S progression in activated T cells (Firposion increases in frequency with successive cell cycles,
et al., 1994), is required to attain Th2 differentiation (Lewhile IL-4 expression requires three cell divisions. Cell
Gros et al., 1990; Heinzel et al., 1993) and is able tocycle progression and cytokine signaling act in con-
rescue Th2 development in the absence of adequatecert to relieve epigenetic repression and can be sup-
costimulation (Seder et al., 1994). That disparate de-planted by agents that hyperacetylate histones and
grees of proliferation might be required for Th1 versusdemethylate DNA. Terminally differentiated cells ex-
Th2 commitment is suggested by the observation thathibit stable epigenetic modification and cell cycle-
IFNg mRNA is induced within 6 hr in activated, IL-12-independent gene expression. These data reveal a
primed cells, while IL-4 mRNA is induced only after 48novel mechanism governing Th cell fate that initially
hr, even when cells are cultivated in the presence ofintegrates proliferative and differentiative signals and
rIL-4 (Lederer et al., 1996).subsequently maintains stability of the differentiated
To test the hypothesis that commitment to lineage-state.
specific gene expression is fundamentally ordered by
the cell cycle, we developed an assay combining twoIntroduction
previously described methods for single cell analysis,
which allows ªcountingº of cell division (Lyons and Par-Activated CD41 helper T (Th) cells exhibit heteroge-
ish, 1994) while quantitating the level and frequency ofneous patterns of cytokine expression that fall into at
cytokine expression (Openshaw et al., 1995) within eachleast two functionally distinct subsets (Mosmann et al.,
generation of cells. Our results demonstrate that the1986). Th1 cells produce IFNg and lymphotoxin, while
cell cycle provides a previously unrecognized level ofTh2 cells produce IL-4, IL-5, and IL-13. Each subset
regulation governingTh differentiation. Lineage-specificmediates distinct immunologic effector functions with
gene activation requires coupling of proliferative andwell characterized roles in protection and pathology dur-
differentiative signals to achieve derepression of epige-ing many infectious and autoimmune diseases (re-
netic constraints. Once a Th cell has differentiated, anviewed in Abbas et al., 1996; O'Garra, 1998). Generally,
open or active gene configuration is a heritable, stablebut with certain exceptions, Th1 responses are associ-
state, providing a cellular memory that allows cell cycle-ated with phagocytic and cell-mediated immunity as
independent reiteration of gene expression.well as autoimmune pathology. Th2 cells, by contrast,
mediate non-phagocytic and extracellular defenses, as
well as serving prominent regulatory or antiinflammatory Results
roles.
The differentiation of naive, uncommitted Th precur- Relationship between Cell Division and Cytokine
sors into mature Th1 or Th2 cells is a complex develop- Gene Expression
mental process that is still not completely understood. We first stimulated a monoclonal population of CFSE-
labeled, naive Th cells from RAG-1-deficient (Mom-
baerts et al., 1992) DO T cell receptor transgenic mice‖ To whom correspondence should be addressed (e-mail: sreiner@
midway.uchicago.edu). (Murphy et al., 1990) and studied the pattern of cytokine
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Figure 1. Cytokine Gene Expression Displays a Hierarchy of Dependence on Cell Division
(A) Patterns of cytokine expression in discrete generations of newly activated, CFSE-labeled naive Th cells were determined by flow cytometry
at the time point designated to the right of each row. Labels above each column indicate the cytokine represented in the y-axis.
(B) Differentiative cytokines do not overcome requirements for cell division. Naive Th cells were cultivated with cytokine and anti-cytokine
additions to induce Th1 or Th2 polarization (see Experimental Procedures), indicated to the left of each row. Results are representative of
eight experiments.
expression versus cell division at designated time points. on cell division for expression of cytokine genes: IL-2
expression is independent of cell division, IFNg is ex-The absence of nontransgenic receptor rearrangements
ensured that the cytokines expressed would be derived pressed at increasing frequency with each cell division,
and IL-4 expression requires a threshold numberof threefrom a population of naive cells (Lee et al., 1996). IL-2,
IFNg, and IL-4 were examined to represent the major cell divisions.
autocrine growth factor of T cells and the signature
cytokines of Th1 and Th2 cells, respectively. The dilution Differentiative Cytokines Operate within
the Constraints of Cell Divisionof intracellular fluorescein successfully distinguished
each generation of dividing T cells in the first few days We next tested whether dependence on cell division
could be modified by the cytokine signals that haveafter stimulation. CFSE did not interfere with the differ-
entiative or proliferative capacity of stimulated cells been considered the most dominant regulators of differ-
entiation (Abbas et al., 1996; O'Garra, 1998). When cul-(data not shown; Wells et al., 1997). Figure 1A demon-
strates that each of the three cytokines has a distinct tures were supplemented with rIL-12 plus anti-IL-4 (Th1-
priming conditions) or rIL-4 plus anti-IL-12 (Th2-primingrelationship to cell division. One day after stimulation,
there was not yet significant cell division. Parental cells conditions), highly polarized Th1-like and Th2-like popu-
lations, respectively, were evident by day 5 (data notexpressed IL-2 at high frequency with only modest ex-
pression of IFNg and undetectable expression of IL-4. shown). At day 2, these cytokine interventions conferred
reciprocal changes in the frequency of expression ofAfter 2 days, there were at least three generations visi-
ble, and IL-2 was expressed at high frequency in every IFNg (Figure 1B).At day3, reciprocal changes were evident
for all three cytokines, with IL-2 and IFNg elevated ingeneration. The frequency with which cells expressed
IFNg increased with each generation, while IL-4 expres- Th1-primed cells and IL-4 elevated in Th2-primed cells.
Despite this polarization, there was remarkably littlesion was still undetectable. After 3 days, at least six
generations were visible and IL-2 continued to be ex- change in division dependence. Specifically, the evolv-
ing Th2 response was not characterized by expressionpressed at high levels by all generations, although its
frequency appeared to decrease after the third genera- of IL-4 at earlier generations but only by increased fre-
quency of expression after the third cell division. Simi-tion. IFNg expression continued to rise in frequency with
each division, while IL-4 expression was barely detect- larly, the evolving Th1 response remained characterized
by a progressively increasing frequency of IFNg expres-able in the fourth generation. Five days after stimulation,
there were several generations present beyond the sixth sion with each successive cell division.
The experiment shown in Figure 1 was performed withcell division. At this point, all three cytokines were ex-
pressed at significant frequency, yet IL-4 was expressed mice from the C57BL background (B10.D2). Because
the BALB mouse strain is predisposed to develop Th2only in the later generations. Experimental variability in
the number of generations present by a given day did responses (GuÈ ler et al., 1996; Guery et al., 1997; Launois
et al., 1997), we tested whether genetic contributionsnot alter the pattern of expression by generation (data
not shown). Thus, there is a hierarchy of dependence could alter the requirements for cell division to achieve
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their cytokine expression patterns. Two days after stim-
ulation, high frequency of IL-2 expression was evident
in dividing cells and in cells arrested at any stage of the
cell cycle (G1, S, or G2/M) (Figure 3). In experiments
examining IFNg and IL-4 expression, Th1-and Th2-prim-
ing conditions were employed, respectively. Three days
after stimulation, Th1-primed cells were examined. In
unimpeded cells, expression of IFNg increased with
each division. Among arrested groups, only those cells
that progressed past G1 phase were capable of express-
ing IFNg, and the frequency was relatively low (Figure
3). After 4 days, unimpeded,Th2-primed cells expressed
IL-4 in the later generations. IL-4 was not expressed if
cells were blocked at any point in the cell cycle, despite
the presence of Th2-priming conditions (Figure 3). Some
IL-4 was detected in rapamycin-treated cells that could
be attributed to incomplete arrest, since IL-4-positiveFigure 2. Genetic Background Does Not Alter Division Dependence
cells were found only in the fourth generation. Arrestfor Cytokine Expression
of cytokinesis with cytochalasin B under Th2-primingNaive, CFSE-labeled Th cells from BALB mice were cultivated with
conditions yielded parental generation cells that werecytokine and anti-cytokine additions to induce Th1 or Th2 polariza-
capable of significant IL-4 expression only if multipletion (indicated in upper left corner of each plot) and analyzed for
cell division and intracellular cytokine expression by flow cytometry nuclear divisions were achieved (data not shown). Entry
4 days after stimulation. Results are representative of six experi- into the cell cycle, therefore, is not required for expres-
ments. sion of IL-2. In addition, expression of CD44 and CD25
were unaffected by all classes of cell cycle inhibitors
(data not shown). In contrast, entry into the cell cycle
effector cytokine expression. Four days after stimula- is necessary for expression of IFNg and IL-4, even when
tion, there were seven generations of dividing BALB Th antigen- and cytokine-receptor ligation are adequate.
cells (Figure 2), which displayed increasing frequency Although expression of IFNg can begin after entry into
of IFNg expression by division in Th1-primed cells and the S phase, it does not reach high frequency without
abrupt expression of IL-4 after three divisions in Th2- further cycling. Expression of IL-4 requires greater than
primed cells (Figure 2). Without cytokine additions, the one cell cycle. Thus, the instructional signals that are
frequency of IL-4 expression in later generations was dominant in promoting differentiated Th1 and Th2 popu-
generally higher in BALB compared to C57 mice (see lations can neither alter the pattern of division-depen-
subsequent figures). Thus, the requirements for cell divi- dent expression (Figures 1B and 2) nor induce effector
sion to achieve effector cytokine expression are inde- cytokine expression in the absence of cellcycle progres-
pendent of cytokine environment, genetic background, sion (Figure 3). This formally demonstrates that coupling
and time. differentiative signals with the proliferative program is
required to achieve effector cytokine gene expression.
Cell Cycle Progression Is Required for Effector
Cytokine Expression Derepression of Effector Cytokines
The above results suggested that changes during entry with Epigenetic Modification
into the cell cycle might be regulating the inducible ex- We next wished to determine why cell cycle progression
pression of effector cytokines. We next wished to deter- is required to activate effector cytokine genes. The pat-
mine whether certain phases of thecell cycle or numbers tern of IFNg and IL-4 expression, even under the influ-
of cycles were required to achieve effector cytokine ence of Th1 and Th2 priming conditions, is reminiscent
expression. We therefore arrested cells with pharmaco- of position effect variegation, wherein only a small popu-
lation of clonal cells express a given gene (reviewed inlogic inhibitors of cell cycle progression and studied
Figure 3. Expression of IL-2 Is Cell Cycle-
Independent, while Expression of IL-4 and
IFNg Is Cell Cycle-Dependent
Naive, CFSE-labeled helperT cells were stim-
ulated in the presence of the drug designated
above each column and are grouped by the
phase of cell cycle arrest (G1, S, or G2/M).
IL-2, IFNg, and IL-4 expression were analyzed
at 2, 3, and 4 days, respectively. Cells ana-
lyzed for IL-2 expression were cultured with-
out cytokine additives. Cells analyzed for
IFNg and IL-4 were cultured in Th1- and Th2-
priming conditions, respectively. Results are
representative of eight experiments, includ-
ing analyses of daily time points and both
C57 and BALB genetic backgrounds.
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Figure 4. Effector Cytokine Expression Is
Derepressed by Histone Acetylation or Cyto-
sine Demethylation
Naive, CFSE-labeled helperT cells stimulated
in the absence (no drug) or presence (1 drug)
of sodium butyrate (Butyrate), or 5-Aza-2-
deoxycytidine (Azacytidine) were analyzed by
flow cytometry for cell division and intracellu-
lar cytokine expression on day 4. The per-
centage of cytokine-positivecells is indicated
in the upper left corner of each plot. Each
horizontal row is a separate experiment; up-
per row depicts cells of C57 origin and lower
row depicts cells of BALB origin. Results are
representative of five separate experiments
for each drug, testing both genetic back-
grounds.
Wakimoto, 1998). This effect is seen when a gene is Differentiative Cytokine Signaling Can Be
Compensated by Epigenetic Modificationtranslocated from accessible euchromatin to inaccessi-
Although IL-4 signaling is required for Th2 differentia-ble heterochromatin. For a population of cells receiving
tion, established Th2 cells can express their signatureuniform developmental signals, epigenetic constraints
cytokines in the absence of IL-4 (Huang et al., 1997; Hu-such as the bulk structure of chromatin and/or methyla-
Li et al., 1997). STAT-6 is a critical downstream regulatortion of DNA might limit the accessibility of genes whose
of the IL-4 receptor with an essential role in Th2 differen-transactivating factors should have been rapidly avail-
tiation (Kaplan et al., 1996). BCL-6, a transcriptional re-able or accumulating upon T cell± and cytokine-receptor
pressor with antagonistic properties for STAT-6-medi-signaling (Ho et al., 1996; Lederer et al., 1996; Zheng
ated IL-4 signaling (Dent et al., 1997), can bind SMRTand Flavell, 1997). Loci that have been repressed can
protein (Dhordain et al., 1997) and thereby associatebecome transcriptionally active following hyperacetyla-
with histone deacetylase (Nagy et al., 1997). Together,tion of histones and demethylation of DNA. We therefore
this suggested that STAT-6 may catalyze epigeneticstimulated naive Th cells in the presence of pharmaco-
modification of its target genes. We therefore attemptedlogic inhibitors of histone deacetylase (sodium butyrate)
to initiate Th2 differentiation in the absence of STAT-6(Kruh, 1982) or cytosinemethylation (5-Aza-2-deoxycyti-
by pharmacologically enforcing epigenetic remodeling.dine) (Jones and Taylor, 1980). We found that both types
STAT-6-null Th cells were stimulated in the presence orof drugs had a profound derepressive effect on the pat-
absence of the indicated drug, washed extensively, andtern of effector cytokine expression. There was mark-
then restimulated in the absence of drug to assess theedly increased frequency of expression of IFNg and IL-4
differentiation of IL-4-expressing cells. Used alone, ei-in drug-treated compared to untreated cells (Figure 4). In
ther the demethylating agent, Azadeoxycytidine, or theaddition, two significant effects that were not observed
hyperacetylating agent, Trichostatin A, yielded minorusing differentiative cytokines were apparent after epi-
increase in the amount of IL-4 secreted by activatedgenetic modifications: higher magnitude expression and
STAT-6-deficient Th cells (Figure 5A). The combinationectopic expression at earlier generations. Specifically,
of the two drugs, however, was highly synergistic inexpression of IFNg in the drug-treated groups included
priming IL-4 secretion upon restimulation (Figure 5A)a much larger proportion of cells fluorescing at theupper
and generating bona fide single-positive (IL-4-express-limits of detection, while expression of IL-4 in drug-
ing, IFNg-negative) STAT-6-deficient Th2 cells (Figure
treated cells could be detected at high frequency at
5B). Thus, the major function of STAT-6 in promoting Th2
least one, if not two, divisions prior to its detection in
differentiation can be readily compensated by enforced
untreated cells. Similar results were obtained using Tri-
epigenetic remodeling.
chostatin A (Yoshida et al., 1990), a specific inhibitor of
histone deacetylase (data not shown). The specificity
of these drugs for a cell cycle-dependent modification of Epigenetic Stability and Effector/Memory Cells
DNA, rather than a direct effect on signaling proteins, From the above results, we would predict that differenti-
was confirmed by the ability to block all enhancement ated effector Th2 cells might exhibit epigenetic changes
of effector cytokine expression with cell cycle inhibitors of cytokine loci. DNA was extracted from a Th1 and
and the inability of these drugs to alter IL-2 expression a Th2 clone and digested with the methyl-insensitive
(data not shown). Thus, the restrictions imposed on the enzyme MspI and the methyl-sensitive enzyme HpaII.
expression of effector cytokines in naive Th cells may Southern analysis with probes of the IL-4 and IL-5 loci
be partly explained by inaccessibility of genetic loci that revealed that these regions were selectively demethy-
require cell cycle-dependent chromatin remodeling and lated in Th2 cells (Figure 6A).We also performed a kinetic
analysis of the early phase of Th2 differentiation. NaiveDNA demethylation for trans-activation.
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rapidly (within 4 hr) express IL-4 and without progressing
through the G1 phase of the cell cycle (Figure 7). Thus,
a stable epigenetic change conferred during differentia-
tion is associated with a stable transition to differen-
tiative signal- (Huang et al., 1997; Hu-Li et al., 1997),
costimulation- (McKnight et al., 1994) and cell cycle-
independent gene expression.
Discussion
Over two decades ago, it was hypothesized that the cell
cycle might provide a window of opportunity to remodel
a gene from an inactive to an active configuration during
differentiation (Weintraub et al., 1978). Our results dem-
onstrate that the cell cycle, indeed, provides fundamen-
tal order to the differentiation of Th cells. An intrinsic
regulatory or counting mechanism permits the orderly
derepression of epigenetically silenced cytokine genes
by coupling differentiative cytokine signals to the prolif-
erative program. Although kinetic delays (Lederer et al.,
1996; Swain et al., 1988) and low frequency (Bucy et al.,
1995) in effector cytokine expression have been re-
ported, our results clearly demonstrate that this is not
due to a simple time-dependent gene induction event
but rather to a process of derepression directly linked
to the cell cycle. Whether the cell cycle is acting only
as a window of opportunity to remodel loci during DNA
synthesis (Aparicio and Gottschling, 1994; Barton andFigure 5. Requirement for STAT-6 in Th2 Differentiation Can Be
Emerson, 1994) or by providing additional opportunitiesCompensated by Epigenetic Modification
to reorganize repressive protein±DNA complexes (BrownNaive, STAT-6-null Th cells cultured in the presence of no drug (-),
5-Aza-2-deoxycytidine (Aza or Azacytidine), Trichostatin A (Tri), or et al., 1997b) or displace transcription factors from mi-
both (A1T or Aza 1 Tricho) were stimulated for 5 days and then totic chromatin (Martinez-BalbaÂ s et al., 1995) awaits fur-
restimulated without drug. IL-4 was measured from supernatants 2 ther testing. The present results also demonstrate that
days after restimulation (A), and IL-4- and IFNg-expressing cells
the requirement for T cell receptor±mediated signals towere detected by flow cytometry 4 days after restimulation (B).
yield cytokine gene expression is not solely to recruitNumbers indicate the percentage of cells in each quadrant. Results
additional trans-acting factors to cytokine genes. In-are representative of three separate experiments.
stead or in addition, theT cell± and costimulatory-recep-
tors must provide sufficient proliferative information to
propel cell cycle progression(s) in order to achieve ef-Th precursors at day 0 exhibited methylation over the
IL-4 locus (Figure 6B). Demethylation occurred as proxi- fector cytokine induction.
Our results argue that cytokine-instructive modelsmal event in Th2-priming, between day 4 and day 7
(Figure 6B), the time at which IL-4-expressing cells reach (Abbas et al., 1996; O'Garra, 1998) are an oversimplifica-
tion of Th differentiation. While highly efficient at drivingsignificant frequency. We also tested for functional im-
plications of the observed epigenetic remodeling by ex- a population of polarized, differentiated Th1 and Th2
cells, IL-12 and IL-4 act within preestablished con-amining the requirements for cell cycle progression to
achieve cytokine gene activation. In contrast to naive straints to catalyze cell cycle-dependent gene activa-
tion. A naive cell can become a Th1 cell with increasingcells, a resting Th2 clone, once stimulated, was able to
Figure 6. Th2 Differentiation Is Accompanied
by Stable Epigenetic Modification
(A) DNA from a Th1 clone and a Th2 clone,
digested with a methyl-insensitive (MspI) or
methyl-sensitive (HpaII) restriction enzyme,
was analyzed by Southern blotting using a
probe for the IL-4 and IL-5 locus.
(B) DNA from a Th2 clone and naive Th cells
undergoing Th2 differentiation at designated
time points was analyzed in the same manner
as (A), using a probe for the IL-4 locus. Arrows
indicate emerging demethylated sites.
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Epigenetic repression, operative at the outset of Th
differentiation, may regulate other cytokine genes dur-
ing T cell ontogeny. The accessibility of the IL-2 pro-
moter is increased in the T cell lineage (Siebenlist et
al., 1986; Rothenberg and Ward, 1996), and the recent
report of monoallelic expression of the IL-2 gene (Hol-
laÈnder et al., 1998) may reflect a developmental transi-
tion when accessibility is so limiting that it favors the
opening of only one of two potential loci. While there
has been extensive evidence for the role of chromatin
in regulating gene expression (for a recent review, see
Kadonaga, 1998), it has been difficult to confirm that
methylation actually represses developmentally regu-
lated genes (Yoder et al., 1997). Our results, together
with previous studies of the IFNg gene (Young et al.,
1994; Melvin et al., 1995) and the recently described
regulatory link between the cell cycle and DNA methyla-
tion (Chuang et al., 1997), lend support to such a mecha-
nism. The principle of cell cycle-dependent epigenetic
remodeling described here is also likely to be applicable
to the regulation of differentiation pathways in other
lymphocytes. Two lineage-specific genes that are highly
regulated by IL-4 signaling, the g1 switch region in B
cells and IL-4 in T cells, appear to be derepressed byFigure 7. Th2 Differentiation Is Accompanied by Cell Cycle-Inde-
analogous remodeling strategies. Consistent with ourpendent Gene Expression
data concerning IL-4 expression, expression of IgG1 isCloned, CFSE-labeled Th2 cells left unstimulated or stimulated in
the absence or presence of the indicated cell cycle inhibitor were associated with changes in DNA methylation (Burger
analyzed by flow cytometry after 4 hr for cell division and IL-4 ex- and Radbruch, 1990) and chromatin (Schmitz and Rad-
pression. Results are representative of three separate experiments. bruch, 1989; Berton and Vitetta, 1990) and requires simi-
lar numbers of cell divisions (Hodgkin et al., 1996).
likelihood after each successive cell cycle but can only Epigenetic regulation of gene expression provides
become a Th2 cell when eight siblings have arisen. In one of the first molecular explanations for the inheri-
this way, perhaps, a protective inflammatory response tance of lymphocyte phenotype, whereby the marking
can become proportionate to the antigenic burden, (or unmarking) of alleles during differentiation confers a
while a regulatory population can evolve that is also stable imprint of rapid effector function, persisting over
metered, albeit differently, by the degree of cell division. subsequent cell divisions. Of practical importance, ma-
IL-12 and IL-4 can direct more polarized states of differ- nipulation of terminal Th differentiation, a common ther-
entiation only by increasing or limiting the initial frequen- apeutic target for infectious and autoimmune diseases,
cies of effector cytokine-expressing cells. The initial ex- might be facilitated by modifying patterns of DNA meth-
pression of effector cytokines may be infrequent or
ylation and/or histone acetylation, in cooperation with
variegated (Wakimoto, 1998), but the rapidly dividing
cytokines or their antagonists. This previously unrecog-
(and dying) nature of activated Th cells may permit the
nized regulatory principle, which integrates proliferativeprompt transition from minor subpopulation into a major
and differentiative signals, may begin to explain numer-portion of surviving cells.
ous observations concerning the regulation of Th cellThe present results provide novel insights into the
differentiation and the stability of lymphocyte pheno-mechanisms by which lineage-specific trans-acting fac-
type. More detailed understanding of this distinctivetors regulate target cytokine genes. The finding that an
clonal counting process may help answer fundamentalessential role for STAT-6 in Th2 differentiation can be
questions about regulatedgene expression innumerouscompensated by epigenetic remodeling highlights an
dividing and differentiating cells.emerging role for cytokines and STAT family members
in regulating chromatin structure. Cytokine signaling in-
Experimental Proceduresfluences accessibility of other genetic loci (Schmitz and
Radbruch, 1989; Berton and Vitetta, 1990; Corcoran et
Analysis of Cell Division and Cytokine Expression
al., 1998; Kang et al., 1998), and both STAT-1 (Zhang et In a modification of a previously described technique (Lyons and
al., 1996; Horvai et al., 1997; Korzus et al., 1998) and Parish, 1994), single cell suspensions of lymph node cells were
STAT-2 (Bhattacharya et al., 1996) have been shown to labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE)
(Molecular Probes) by incubating 1 3 107 cells/ml in PBS with 10associate with transcriptional coactivators that possess
mM CFSE for 8 min at room temperature. Labeling was stoppedhistone acetyltransferase activity (Ogryzko et al., 1996).
with the addition of 1 volume fetal calf serum (FCS), and cells wereThe precise mechanisms that mediate repression of Th2
washed an additional three times with T cell media (Iscove's mediacytokines (Chuvpilo et al., 1993; Klein-Hessling et al.,
containing 10% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 mg/ml
1996; Dent et al., 1997; Kubo et al., 1997; Weiss et al., streptomycin, and 50 mM 2-mercaptoethanol) prior to stimulation.
1997) and the molecular details of IL-4-mediated epige- Staining for intracellular cytokines was performed using a modifica-
netic remodelingare likely tobe complex and will require tion of standard techniques (Openshaw et al., 1995). PMA (50 ng/
ml) and ionomycin (500 ng/ml) were added to cultures 4 hr prior tofurther analysis.
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harvest. Two hr prior to harvest, Brefeldin A (1 mg/ml) was added buffer (sodium phosphate buffer [pH 7.2], 7% SDS, 1 mM EDTA,
and 1003 mg/ml salmon sperm DNA) and incubated overnight withto cultures. At harvest, cells were stained with anti-CD4 Tricolor-
conjugate (Caltag) for 30 min at 48C in balanced salt solution/1% DNA probes labeled by random priming. The filter was washed once
for 5 min with 23 SSC at 258C and twice for 30 min at 658C in 23FCS and then washed twice in buffered saline before fixation in
buffered saline/4% paraformaldehyde for 10 min at room tempera- SSC containing 0.1% SDS and then exposed for autoradiography.
The IL-4 probe was prepared from a 2.4 kb EcoRI/StuI fragmentture. After fixation, cells were washed twice with balanced salt solu-
tion/1% FCS and resuspended in permeabilization buffer (PBS, within intron 2. The 59 end encompasses a known enhancer (Henkel
and Brown, 1994). The IL-5 probe was prepared from a PCR product0.1% saponin, and 1% FCS) containing either anti-IL-2-, anti-IFNg-,
anti-IL-4-, or control Ig-PE-conjugate (2 mg/ml) (PharMingen) for of the promoter encompassing nucleotides 21175 to 22.
30 min. In the experiment using STAT-6-null cells, two-color flow
cytometry was done on non-CFSE-labeled cells using anti-IFNg-
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